Skip to main content
Jeffrey Nau, MD, Otolaryngology (ENT), Louisville, KY

Jeffrey C Nau MD


Physician

Join to View Full Profile
  • 3999 Dutchmans Ln"# 1"Louisville, KY 40207

  • Phone+1 502-897-7300

  • Fax+1 502-897-3332

Join Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Jeffrey Nau, MD is an otolaryngologist in Louisville, Kentucky. He is currently licensed to practice medicine in Kentucky and Indiana.

Education & Training

  • University of Louisville School of Medicine
    University of Louisville School of MedicineResidency, Otolaryngology - Head and Neck Surgery, 2004 - 2008
  • University of Louisville School of Medicine
    University of Louisville School of MedicineInternship, Otolaryngology - Head and Neck Surgery, 2003 - 2004
  • University of Louisville School of Medicine
    University of Louisville School of MedicineClass of 2003
  • University of Missouri-Columbia School of Medicine
    University of Missouri-Columbia School of MedicineClass of 2003

Certifications & Licensure

  • KY State Medical License
    KY State Medical License 2008 - 2026
  • IN State Medical License
    IN State Medical License 2020 - 2025
  • Otolaryngology
    American Board of Otolaryngology - Head and Neck Surgery Otolaryngology

Publications & Presentations

PubMed

Press Mentions

  • Oyster Point Pharma’s OC-01 Nasal Spray Meets Primary Endpoint in Phase 2 Mystic Trial in Subjects with Dry Eye Disease
    Oyster Point Pharma’s OC-01 Nasal Spray Meets Primary Endpoint in Phase 2 Mystic Trial in Subjects with Dry Eye DiseaseJanuary 13th, 2020
  • Oyster Point Announces Positive Results from Two Separate Phase 2b Clinical Trials of the Company’s Investigational Treatments for Dry Eye Disease
    Oyster Point Announces Positive Results from Two Separate Phase 2b Clinical Trials of the Company’s Investigational Treatments for Dry Eye DiseaseOctober 24th, 2018
  • Oyster Point Pharma Announces Positive Results from Phase 2 Clinical Trial of the Company’s Investigational Treatment for Dry Eye Disease
    Oyster Point Pharma Announces Positive Results from Phase 2 Clinical Trial of the Company’s Investigational Treatment for Dry Eye DiseaseJuly 12th, 2018
  • Join now to see all